Fierce Pharma Feature: Small molecule biomarkers in precision medicine

Por um escritor misterioso

Last updated 02 abril 2025

Fierce Pharma Feature: Small molecule biomarkers in precision medicine

This contributed piece to Fierce Pharma discusses small molecule biomarkers & how next-gen mass spectrometry is enabling their discovery on an entirely new scale.

Cancers, Free Full-Text

Molecules imagined using advanced artificial intelligence show promising results in pre-clinical experiments

Latest news on gen AI: Incredible Health taps AI for hiring

Fierce Pharma Feature: Small molecule biomarkers in precision medicine

Metabolomics for personalized medicine: the input of analytical chemistry from biomarker discovery to point-of-care tests

Value Creation in Precision Medicine through Biomarkers - FutureBridge

Fierce Pharma Feature: Small molecule biomarkers in precision medicine

EGFR Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Pathogens, Free Full-Text

Applying the Power of Omics to R&D

Small Molecules Targeting DNA Polymerase Theta (POLθ) as Promising Synthetic Lethal Agents for Precision Cancer Therapy

Frontiers Emerging Alzheimer's disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions

Healthcare, Free Full-Text

Recomendado para você